Almost one billion people globally live in urban informal settlements. This burgeoning population is exposed to living conditions that may predispose them to differential disease burden.

We have field sites in Brazil, India and Bangladesh where we conduct studies to assess the burden of diseases in urban slum settlements.Products of our basic research (e.g., new diagnostic tests) are applied at our field sites to assess disease burden.